Business Wire

ALEPHYA-EDUCATION

2.9.2024 05:31:33 CEST | Business Wire | Press release

Share
AlephYa Education Welcomes Majority Investment from TA

AlephYa Education (“AlephYa” or “Company”), a leading pan-GCC education provider, today announced a majority investment from TA Associates (“TA”), a leading global private equity firm, to support its next phase of growth. As part of the transaction, existing investors Gulf Investment Corporation (“GIC”) and Oman International Development and Investment Company SAOG (“Ominvest”) will retain a meaningful stake in the business, partnering closely with TA. Ashmore Investment Saudi Arabia (“Ashmore”), an investor in AlephYa since 2017, will fully exit its investment in the Company.

Founded in 2017, AlephYa has become a fast-expanding school platform committed to providing high-quality, affordable education to local and expat families across the Middle East. The Company’s network of schools offers a mix of American, British and local curricula designed to empower students with the skills to become future leaders while retaining their national heritage. Today, AlephYa owns and operates 13 schools across Saudi Arabia, UAE and Oman, with a combined enrollment of over 18,500 students.

“Since AlephYa’s founding only seven years ago, the Company has established a strong, diversified platform driven by an impressive track record of M&A and operational excellence. As experienced investors in the education space, we see great potential for AlephYa’s continued expansion, both organically and through strategic acquisitions,” said Dhiraj Poddar, Managing Director at TA. “We are thrilled to partner with the AlephYa team to achieve further scale and bring high-quality, affordable education to more communities across the GCC,” added Vishal Gupta, Director at TA.

“TA shares our commitment to academic excellence, and their investment provides a major opportunity to enhance our educational infrastructure, improve our facilities and increase our impact on new and existing students,” said Shailesh Doshi, CEO and Co-Founder of AlephYa. “We are excited to welcome TA as an investor and look forward to leveraging their deep expertise in scaling companies to reach our full potential,” added Nadeem Masud and Chandra Tiwari, Co-Founders of AlephYa.

“Since investing in the Company in 2017, it has been a privilege to significantly scale AlephYa working alongside Ominvest and GIC during a period of such transformational growth,” commented Ibrahim Assem, Head of Private Equity, MENA at Ashmore Group plc. “We wish AlephYa and its shareholders the best as they solidify its position as one of the largest school groups in the region,” added Kartik Patel, Head of Alternatives at Ashmore Investment Saudi Arabia.

“We believe AlephYa is well-positioned to sustain its rapid growth as the demand for accessible, high-quality education continues to increase across the GCC. This transaction is part of GIC’s strategy to partner with leading global firms and we look forward to the next chapter ahead in partnership with TA,” said Mohammad Al-Fares, Head of Diversified Projects Division at GIC.

“We are pleased to welcome TA as a fellow investor in AlephYa. As knowledgeable investors in the education sector, we are confident TA’s partnership will enable us to enhance AlephYa’s offering and further strengthen its footprint. This investment is aligned with Ominvest’s Purpose Statement of transforming businesses to enrich societies,” commented Badar Al Shanfari, Chief investment Officer (Private Equity) at Ominvest.

PwC Middle East served as financial advisor to TA. Al Tamimi & Company and Goodwin Procter LLP provided legal counsel to TA. Financial terms of the transaction were not disclosed.

About AlephYa Education

Established in 2017, AlephYa is a leading educational group that owns and operates schools across the GCC. AlephYa has a core focus on nurturing global citizens and empowering students with the skills to become future leaders, providing high-quality education that is affordable and accessible to every child. The platform’s approach to education is focused around the five attributes of academic excellence, community, collaboration, heritage and corporate and social responsibility. To learn more, visit www.alephyaeducation.com.

About Ashmore Investment Saudi Arabia

Based in Riyadh, Ashmore Investment Saudi Arabia was founded in 2014 and is part of Ashmore Group plc. Ashmore Group is one of the world's leading investment managers dedicated to Emerging Markets with USD 49.5 billion (as at 30 June 2024) invested for clients across the globe. These include central banks, government and corporate pension funds, institutions and high net worth individuals. Ashmore offers a number of investment themes, including External Debt, Local Currency, Corporate Debt, Blended Debt, Equities, Alternatives, Overlay/Liquidity and Multi-Asset. To learn more, visit www.ashmoregroup.com.

About Gulf Investment Corporation

Gulf Investment Corporation (GIC) is an investment company incorporated in the State of Kuwait on November 15, 1983 as a Gulf Shareholding Company. It is equally owned by the governments of the six-member states of the Gulf Cooperation Council (GCC). GIC was formed to foster economic growth, economic diversification and capital markets development across the GCC region. To learn more, visit www.gic.com.kw.

About Ominvest

Founded in 1983 and listed on the Muscat Securities Exchange, Ominvest is a leading investment company in the region with a track record of consistent profits and dividend payments to shareholders. At Ominvest, we take a global approach to investing and hold a diversified portfolio of investments in markets beyond Oman, including the GCC, Asia and other international growth markets. Our investments are diversified across insurance, banking & finance, private equity, global capital market investments, real estate and technology. www.ominvest.com

About TA

TA is a leading global private equity firm focused on scaling growth in profitable companies. Since 1968, TA has invested in more than 560 companies across its five target industries – technology, healthcare, financial services, consumer and business services. Leveraging its deep industry expertise and strategic resources, TA collaborates with management teams worldwide to help high-quality companies deliver lasting value. The firm has raised $65 billion in capital to date and has over 150 investment professionals across offices in Boston, Menlo Park, Austin, London, Mumbai and Hong Kong. For more information, visit: www.ta.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240901234095/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datavault AI Announces Board of Directors Has Requested Management’s Complete Plan for Dividend Spin-Out of Acoustic Sciences Division into Stand-Alone Public Company7.5.2026 15:07:00 CEST | Press release

Initial planning calls for Data Sciences Division to focus efforts in cyber secure infrastructure with dedication in fintech and patented Information Data Exchange® (IDE®) Management will harness its API Media acquisition, robust patent portfolio, ADIO® Inaudible Tones, WiSA® and Dolby® partnerships to establish worldwide acoustic industry standards in high-definition wireless transmission, spatial-audio control and interoperability Plan includes API media’s stand-alone and renewed execution of WiSA semiconductor and software modules strategy with an R&D effort targeted to new robotic and drone applications Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ:DVLT), a pioneering technology licensing company seeking to redefine data valuation, monetization, and secure Web 3.0 experiences, today announced that Company management has commenced its evaluation of a potential dividend spin-out of the Company’s Acoustic Sciences division which includes its ADIO®, WiSA®, Event Citadel™,

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release

First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye